Abaloparatide 3mg

Research Specifications

Sequence:
34 amino acids (modified PTHrP 1-34)
CAS:
247062-33-5
Molecular Weight:
3961 Da
Vial:
3mg lyophilized (~37 days at 80 mcg/day)
Purity:
≥98% HPLC verified
Storage:
−20°C long-term / 4°C up to 4 weeks reconstituted

Abaloparatide 3mg

Synthetic PTHrP analog (34 amino acids)

CAS: 247062-33-5

−86%

Vertebral fracture risk reduction

ACTIVE Trial (JAMA 2016)

Daily SC

Dosing route

80 mcg/day protocol

2017

FDA approval year

Tymlos (Radius Health)

Receptor Targets

PTH1R (RG state)Biased agonism → anabolic bone signaling
$134.99In Stock
Buy Now
≥98% Purity Verified Free Shipping $200+ HPLC Tested
Approved

FDA approved (2017) as Tymlos

Approved for postmenopausal osteoporosis at high fracture risk. 2-year cumulative treatment limit. Research use only outside approved indication.

Also Known As

AbaloparatideTymlosBA058PTHrP analog

Published References

  1. 1.
    Miller PD, Hattersley G, Riis BJ, et al.. Effect of Abaloparatide vs Placebo on New Vertebral Fractures in Postmenopausal Women With Osteoporosis: The ACTIVE Randomized Clinical Trial. JAMA (2016) PMID: 27532272

Research Use Only. This product is intended for in-vitro laboratory research only. Not for human consumption, injection, or therapeutic use. Not medical advice. Always consult applicable regulations in your jurisdiction.

Price Comparison

SupplierPurityPriceShipping
our verified supplier>98% HPLC$134.99Free over $200
Generic Research SuppliersVaries (often <95%)Similar–HigherVaries
Pharmaceutical (Rx only)Pharmaceutical gradeNot available for researchRx required

Abaloparatide 3mg

$134.99

Buy Now